Compare MGM Resorts International (MGM) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MGM Resorts International vs TransMedics Group Inc — how do they compare? MGM Resorts International trades at $46.57 (market cap $11.86B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: MGM Resorts International is far larger — about 4.7× TransMedics Group Inc's market cap, and MGM Resorts International pays a 0.03% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| MGM | TMDX | |
|---|---|---|
Market Cap | $11.86B | $2.54B |
Sector | Consumer Cyclical | Technology |
52-Week High | $50.69 | $150.42 |
52-Week Low | $30.72 | $61.99 |
Enterprise Value | $40.90B | $2.94B |
Dividend Yield | 0.03% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MGM Resorts International
MGM Resorts is the largest resort operator on the Las Vegas Strip with 35,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Cosmopolitan, Luxor, New York-New York, and CityCenter. The Strip contributed approximately 49% of total EBITDAR in the prepandemic year of 2019. MGM also owns U.S. regional assets, which represented 29% of 2019 EBITDAR. we estimate MGM's U.S. sports and iGaming operations are currently a mid-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM Macau casinos with a new property that opened on the Cotai Strip in early 2018. Further, we estimate MGM will open a resort in Japan in 2027.
Read more on MGM →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
